Consultations

Search consultations and choose filters to show only the results you want

Consultation topic

Publication date

379 consultations

Equality and Human Rights Consultation - NICE TA 416 - Osimertinib for Treating Locally Advanced or Metastatic EGFR T790M Mutation-Positive Non-Small-Cell Lung Cancer

Published 21 September 2018Closed

Equality and Human Rights Consultation - NICE TA - Dabrafenib in Combination with Trametinib for Adjuvant Treatment of Resected BRAF V600 Positive Malignant Melanoma

Published 18 September 2018Closed

Equality and Human Rights Consultation - NICE NG 106 - Chronic Heart Failure in Adults: Diagnosis and Management

Published 12 September 2018Closed

Equality and Human Rights Consultation - NICE NG 105 - Preventing Suicide in Community and Custodial Settings

Published 10 September 2018Closed

Equality and Human Rights Consultation - NICE TA - Ocrelizumab for Treating Primary Progressive Multiple Sclerosis

Published 10 September 2018Closed

Equality and Human Rights Consultation - NICE NG 104 - Pancreatitis

Published 06 September 2018Closed

Equality and Human Rights Consultation - NICE TA - Cabozantinib for Untreated Advanced Renal Cell Carcinoma

Published 28 August 2018Closed

Equality and Human Rights Consultation - NICE TA - Tofacitinib for Treating Active Psoriatic Arthritis after Inadequate Response to DMARDs

Published 23 August 2018Closed

Equality and Human Rights Consultation - NICE NG 103 - Flu Vaccination: Increasing Uptake

Published 22 August 2018Closed

Equality and Human Rights Consultation - NICE TA - Inotuzumab Ozogamicin for Treating Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia

Published 09 August 2018Closed

Equality and Human Rights Consultation - NICE NG 102 - Community Pharmacies: Promoting Health and Wellbeing

Published 02 August 2018Closed

Equality and Human Rights Consultation - NICE TA - Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma

Published 25 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Lenvatinib and Sorafenib for Treating Differentiated Thyroid Cancer After Radioactive Iodine

Published 20 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Dinutuximab Beta for Treating High-Risk Neuroblastoma

Published 20 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Lutetium (177lu) Oxodotreotide for Treating Unresectable or Metastatic Neuroendocrine Tumours

Published 20 July 2018Closed

Equality and Human Rights Consultation - NICE NG 101 - Early and Locally Advanced Breast Cancer: Diagnosis and Management

Published 18 July 2018Closed

Equality and Human Rights Consultation - NICE NG 99 - Brain Tumours (Primary) and Brain Metastases in Adults

Published 17 July 2018Closed

Equality and Human Rights Consultation - NICE NG 100 - Rheumatoid Arthritis in Adults: Management

Published 17 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Alectinib for Untreated Anaplastic Lymphoma Kinase Positive Advanced Non-Small-Cell Lung Cancer

Published 16 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Ixekizumab for Treating Active Psoriatic Arthritis After DMARDs

Published 16 July 2018Closed

Pages

Back to top